Global food giants deepen price cuts to tempt China's wary shoppers
China's shoppers shift towards locally-made products
Market is expected to remain weak
Demand for infant health foods resilient
By Richa Naidu
LONDON, Oct 24 (Reuters) -International companies such as Danone DANO.PA and Nestle NESN.S have deepened price cuts or are seeking to boost online shopping volumes to win over China's increasingly reluctant customers, executives said.
China's economy, the world's second largest, grew at the slowest pace since early 2023 in the third quarter.
Consumption and industrial output figures last month beat forecasts, but a property sector crisis remains a challenge for Beijing as it tries to boost growth.
For international players, an issue is consumers' increased preference for locally made products, which have improved in quality and can be cheaper than the big brands of foreign multinationals, investors say.
Unilever, which makes Dove soap and Knorr soup bases, reported on Thursday that underlying sales at its China business declined by low-single digits and that market weakness extended across categories.
CEO Hein Schumacher said market growth in China will remain "subdued" for some quarters yet and that the company was revamping the way it sells products in China.
"In China, the consumer has changed shopping behaviour quite fast, with some particular digital channels that have grown exponentially - here, we are resetting to make sure we follow that changing consumer," Schumacher said in a media call.
French dairy company Danone has found its more specialised products, including infant formula and vitamin drinks are more resilient during the downturn.
"In a consumer landscape which is relatively soft, the consumer is still very intentional about where they believe they're getting value for money," finance chief Juergen Esser told Reuters.
It has also had some success by cutting prices to attract bargain-hunters.
The company which makes Activia yoghurt, Evian bottled water and Aptamil infant formula, cut prices by 2.2% for its business that includes Australia, China, Japan and New Zealand, while volumes grew by more than 10% and like-like-like sales rose 8%.
Nestle and Danone lowered prices in their businesses that include China from the second quarter and deepened the cuts more recently. Unilever did not disclose price changes for China.
Other Danone products in demand are its Chinese vitamin drink brand Mizone, high-protein dairy and specialty infant nutrition items such as those used by mothers who had C-sections.
"Medical nutrition is a no brainer, because macro trends (towards health) are in our favour," Esser said.
Nestle, the world's biggest food maker, last week said it also cut prices - by 1.5% - in China in the nine months to Sept. 30, but drove sales volumes only by 3.9% due to the "low inflation environment".
Echoing the trend towards premium specialised products seen by Danone, Nestle CFO Anna Manz pointed to good performance from infant nutrition products, citing in particular the company's NAN baby milk for babies that have specific allergies or challenges.
Reporting by Richa Naidu; Editing by Josephine Mason and Barbara Lewis
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
